New Opportunities for Targeting the Androgen Receptor in Prostate Cancer

被引:19
|
作者
Centenera, Margaret M. [1 ,2 ,3 ]
Selth, Luke A. [1 ,2 ,4 ]
Ebrahimie, Esmaeil [4 ]
Butler, Lisa M. [1 ,2 ,3 ]
Tilley, Wayne D. [1 ,2 ,4 ]
机构
[1] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA 5005, Australia
[3] South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia
[4] Univ Adelaide, Adelaide Med Sch, Dame Roma Mitchell Canc Res Labs, Adelaide, SA 5005, Australia
来源
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
HEAT-SHOCK-PROTEIN; RANDOMIZED PHASE-II; LIGAND-BINDING DOMAIN; N-TERMINAL DOMAIN; BF3; SITE; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; STRUCTURAL BASIS; HSP90; CHAPERONE; GENE-MUTATIONS;
D O I
10.1101/cshperspect.a030478
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent genomic analyses of metastatic prostate cancer have provided important insight into adaptive changes in androgen receptor (AR) signaling that underpin resistance to androgen deprivation therapies. Novel strategies are required to circumvent these AR-mediated resistance mechanisms and thereby improve prostate cancer survival. In this review, we present a summary of AR structure and function and discuss mechanisms of AR-mediated therapy resistance that represent important areas of focus for the development of new therapies.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Targeting the androgen receptor in prostate cancer
    Culig, Zoran
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1427 - 1437
  • [2] New Approaches to Targeting the Androgen Receptor Pathway in Prostate Cancer
    Velho, Pedro Isaacsson
    Bastos, Diogo Assed
    Antonarakis, Emmanuel S.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 228 - 240
  • [3] Targeting the androgen receptor pathway in prostate cancer
    Chen, Yu
    Sawyers, Charles L.
    Scher, Howard I.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (04) : 440 - 448
  • [4] New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer
    Assi, Rita
    Temraz, Sally
    Shamseddine, Ali
    Mukherji, Deborah
    [J]. CURRENT DRUG TARGETS, 2016, 17 (03) : 290 - 302
  • [5] New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
    Sural, Yavuz Selim
    Cal, Cag
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 106 - 110
  • [6] Targeting the androgen receptor in prostate and breast cancer: several new agents in development
    Proverbs-Singh, Tracy
    Feldman, Jarett L.
    Morris, Michael J.
    Autio, Karen A.
    Traina, Tiffany A.
    [J]. ENDOCRINE-RELATED CANCER, 2015, 22 (03) : R87 - R106
  • [7] Rational targeting of the Androgen receptor interactome in prostate cancer
    Ravindranathan, Preethi
    Tilley, Wayne
    Raj, Ganesh V.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [8] New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
    Attard, Gerhardt
    Richards, Juliet
    de Bono, Johann S.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1649 - 1657
  • [9] The evolution of prostate cancer therapy: targeting the androgen receptor
    Aragon-Ching, Jeanny B.
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [10] Targeting Continued Androgen Receptor Signaling in Prostate Cancer
    Massard, Christophe
    Fizazi, Karim
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (12) : 3876 - 3883